Toggle navigation
Home
Search
Services
Blog
Contact
About
Monoclonal Antibody Assay for Apoliprproteins A-1 and B
Foley, Thomas J.
Hybridoma Sciences, Inc., Fountain Valley, CA, United States
Search 35 grants from Thomas Foley
Search grants from Hybridoma Sciences, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Innate Immunity Training Program
Administrative Core
Molecular Imaging of Targeted Cardiac Gene Therapy
Mechanisms of Topoisomerase Poisons
Biocalorimetry Center
Recently added grants:
Macrophage-based ovarian cancer immunotherapy
Mechanism-based drug repurposing and novel treatments for glioblastoma
Targeting lymph node metastases to prevent cancer progression
Smart and self-reporting clinical nano carriers for drug delivery
The Role of 27-hydroxycholesterol in Breast Cancer: A Population-Based Multiethnic Study
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44HL033043-03
Application #
3508402
Study Section
(SSS)
Project Start
1984-09-30
Project End
1988-06-09
Budget Start
1987-06-10
Budget End
1988-06-09
Support Year
3
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Hybridoma Sciences, Inc.
Department
Type
DUNS #
City
Fountain Valley
State
CA
Country
United States
Zip Code
92708
Related projects
NIH 1987
R44 HL
Monoclonal Antibody Assay for Apoliprproteins A-1 and B
Foley, Thomas J. / Hybridoma Sciences, Inc.
NIH 1986
R44 HL
Monoclonal Antibody Assay for Apoliprproteins A-1 and B
Cowley, Daniel B. / Hybridoma Sciences, Inc.
Publications
Rothwell, T C; Kamanna, V S; Jin, F Y et al.
(1995)
Characterization of a monoclonal antibody (HB-22) and development of an ELISA for human apolipoprotein A-I.
Clin Chem 41:1150-8
Comments
Be the first to comment on Thomas Foley's grant